Streetbeat News

Revenues

DIS

ValueAct Capital Management has identified Disney's theme parks as a key growth business, highlighting the potential for significant revenue and profit expansion in this segment.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:24 pm

COST

Costco Wholesale (NASDAQ:COST) reported Q2 earnings of $3.920 per share, beating estimates by 8.59%, but missed revenue estimates with $58.442B against the expected $59.156B, marking a 5.75% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:16 pm

MDB

MongoDB has issued its financial guidance for Q1 and the full year of fiscal 2025, projecting lower earnings and revenue than analysts expected. The company anticipates Q1 EPS to be between $0.34 and $0.39, versus the estimated $0.62, and revenue between $436M and $440M, compared to the expected $447.47M. For the full year, MongoDB forecasts EPS between $2.27 and $2.49, against the estimated $3.34, and revenue between $1.9B and $1.93B, lower than the $2.03B estimate. This guidance accounts for over $80 million of FY24 revenue from multi-year term licenses and unused Atlas commitments not expected to be realized in FY25.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:11 pm

DOCU

DocuSign forecasts Q1 total revenue to be between $704M-$708M, surpassing the estimated $700.06M. Additionally, the company projects its FY25 total revenue to range from $2.915B to $2.927B, exceeding the $2.9B estimate.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:07 pm

PRTS

CarParts.com forecasts its 2024 comparable net sales to range from a decrease of 2% to an increase of 2%, with a gross margin expectation of 30%-32%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 9:05 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) received mixed analyst ratings, with a recent shift towards more bullish views. The average 12-month price target is now $38.2, up from $35.33, indicating an 8.12% increase. Analyst actions include ratings adjustments and price target changes, reflecting updated market conditions and company performance. OrthoPediatrics, a medical device company focused on pediatric orthopedic products, showed a revenue growth of 14.37% for the quarter ending September 30, 2023, but its growth rate is below the Health Care sector average. The company has a notable net margin of -11.49% and an ROE of -1.22%, with a debt-to-equity ratio of 0.0.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:00 pm

META

SONY

UMGNF

WBD

TikTok is in a licensing dispute with Universal Music Group NV (UMGNF) and is nearing the end of its deal with the National Music Publishers Association (NMPA), leading to the removal of music co-written by UMGNF songwriters. The NMPA advises members to negotiate directly with TikTok or explore enforcement options. TikTok's parent, ByteDance, reported Q3 2023 revenues of $30.9 billion, close to Meta Platforms Inc's (META) $34 billion. The dispute could escalate if other publishers like Sony Group Corp. (SONY) and Warner Bros. Discovery Inc's (WBD) Warner Chappell join, affecting more music on the platform.

Portfolio Pulse from Franca Quarneti

March 07, 2024 | 8:37 pm

UNFI

United Natural Foods (NYSE:UNFI) has been the subject of 4 analyst ratings over the past three months, showing a shift towards a more bearish outlook. The average 12-month price target has been lowered to $13.38 from $15.00, indicating a 10.8% decrease. Analysts from Roth MKM, Wells Fargo, and Jefferies have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. United Natural Foods, a distributor of natural and organic foods, has shown revenue growth but faces challenges in profitability, debt management, and efficiency metrics.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 8:00 pm

PLTR

Recent analysis of Palantir Technologies (NYSE:PLTR) by 9 experts shows a mix of opinions, with an updated average 12-month price target of $20.22, up from $18.25. Ratings range from bullish to bearish, with recent adjustments reflecting a generally positive outlook. Palantir's financial performance indicates strong revenue growth but challenges in profitability and asset utilization. The company's market positioning and analyst expectations suggest potential for future growth despite current operational challenges.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 7:01 pm

JWN

Nordstrom (NYSE:JWN) received mixed ratings from 9 analysts, with a consensus 12-month price target of $17.78, reflecting a 10.37% increase from the previous target. The ratings range from 'Hold' to 'Underweight', with adjustments made by analysts from firms like Jefferies, Goldman Sachs, and Citigroup. Despite a -6.37% revenue decline and a high debt-to-equity ratio, Nordstrom's net margin and ROE outperform industry benchmarks, indicating efficient cost management and strong financial health.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 7:00 pm